<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39232821</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">0778-7367</ISSN><JournalIssue CitedMedium="Print"><Volume>82</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Archives of public health = Archives belges de sante publique</Title><ISOAbbreviation>Arch Public Health</ISOAbbreviation></Journal><ArticleTitle>Two-year epidemiology of post-COVID-19 conditions in Bangladesh: a cohort study of post-COVID-19 from 12,925 SARS-CoV-2 cases between July and December 2021-2023 in Bangladesh.</ArticleTitle><Pagination><StartPage>148</StartPage><MedlinePgn>148</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">148</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13690-024-01358-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Post-COVID-19 conditions (PCCs), also known as long COVID, is persistently debilitating disorders that need investigation on their incidence, morbidity, and case-fatality rate.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The objectives of this cohort study were to determine the incidence, characteristics, case-fatality, morbidity, and recovery of post-COVID-19 symptoms throughout a two-year period of observation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a population-based cohort study of post-COVID-19 cases among 12,925 SARS-CoV-2 positive individuals in eight administrative districts of Bangladesh between July and December 2021-2023. PCC was diagnosed according to WHO clinical diagnostic criteria, and the screening procedure was completed through a household screening process.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of PCC was 3.6%, the case-fatality rate was 1.92%, and the recovery rate was 9.0%. The significant predictors of PCC morbidity were geographical distribution, vaccination, comorbidities, and a longer duration of symptoms or multiple symptoms (p&#x2009;&lt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Nearly 465 out of 522 people suffering from PCC are persistent and have a significant disability. However, the rate of recovery was 9.0%. It is necessary to investigate approaches to improve the recovery of PCC in Bangladesh.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sarker</LastName><ForeName>Altaf Hossain</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Jashore University of Science and Technology (JUST), Jashore, 7408, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabir</LastName><ForeName>Md Feroz</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy and Rehabilitation, Jashore University of Science and Technology (JUST), Jashore, 7408, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>K M Amran</ForeName><Initials>KMA</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy and Rehabilitation, Jashore University of Science and Technology (JUST), Jashore, 7408, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahan</LastName><ForeName>Sharmila</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy and Rehabilitation, Jashore University of Science and Technology (JUST), Jashore, 7408, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>Md Zahid</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy and Rehabilitation, Jashore University of Science and Technology (JUST), Jashore, 7408, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>Tofajjal</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy and Rehabilitation, Jashore University of Science and Technology (JUST), Jashore, 7408, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Sohel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Directorate of Student's Welfare, Bangladesh University of Engineering and Technology, Dhaka, 1000, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Raju</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Dhaka College of Physiotherapy, Dhaka, 1207, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Islam</LastName><ForeName>Md Waliul</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Centre for the Rehabilitation of the Paralysed (CRP), Savar, Dhaka, 1343, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahid</LastName><ForeName>Iqbal Kabir</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Jashore University of Science and Technology (JUST), Jashore, 7408, Bangladesh. ikjahid_mb@just.edu.bd.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>23-FoBST-06</GrantID><Agency>Jashore University of Science and Technology through the University Grants Commission (UGC)</Agency><Country/></Grant><Grant><GrantID>23-FoBST-06</GrantID><Agency>Jashore University of Science and Technology through the University Grants Commission (UGC)</Agency><Country/></Grant><Grant><GrantID>23-FoBST-06</GrantID><Agency>Jashore University of Science and Technology through the University Grants Commission (UGC)</Agency><Country/></Grant><Grant><GrantID>23-FoBST-06</GrantID><Agency>Jashore University of Science and Technology through the University Grants Commission (UGC)</Agency><Country/></Grant><Grant><GrantID>23-FoBST-06</GrantID><Agency>Jashore University of Science and Technology through the University Grants Commission (UGC)</Agency><Country/></Grant><Grant><GrantID>23-FoBST-06</GrantID><Agency>Jashore University of Science and Technology through the University Grants Commission (UGC)</Agency><Country/></Grant><Grant><GrantID>23-FoBST-06</GrantID><Agency>Jashore University of Science and Technology through the University Grants Commission (UGC)</Agency><Country/></Grant><Grant><GrantID>23-FoBST-06</GrantID><Agency>Jashore University of Science and Technology through the University Grants Commission (UGC)</Agency><Country/></Grant><Grant><GrantID>23-FoBST-06</GrantID><Agency>Jashore University of Science and Technology through the University Grants Commission (UGC)</Agency><Country/></Grant><Grant><GrantID>23-FoBST-06</GrantID><Agency>Jashore University of Science and Technology through the University Grants Commission (UGC)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Public Health</MedlineTA><NlmUniqueID>9208826</NlmUniqueID><ISSNLinking>0778-7367</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bangladesh</Keyword><Keyword MajorTopicYN="N">Cohort</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 conditions</Keyword><Keyword MajorTopicYN="N">Recovery</Keyword><Keyword MajorTopicYN="N">Case-fatality</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>5</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39232821</ArticleId><ArticleId IdType="pmc">PMC11373300</ArticleId><ArticleId IdType="doi">10.1186/s13690-024-01358-6</ArticleId><ArticleId IdType="pii">10.1186/s13690-024-01358-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization: WHO. Post COVID-19 condition (Long COVID) [Internet]. 2022. https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>Coronavirus disease (COVID-19). Post COVID-19 condition [Internet]. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition.</Citation></Reference><Reference><Citation>Mateu L, Teb&#xe9; C, Loste C, Santos JR, Llad&#xf3;s G, L&#xf3;pez CR et al. Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study. The Lancet Regional Health - Europe [Internet]. 2023;33:100724. 10.1016/j.lanepe.2023.100724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10636281</ArticleId><ArticleId IdType="pubmed">37954002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long covid: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;607. 10.1093/infdis/jiac136. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MA, Hossain KM, Saunders K, et al. Prevalence of long covid symptoms in Bangladesh: a prospective inception cohort study of covid-19 survivors. BMJ Global Health. 2021;6(12). 10.1136/bmjgh-2021-006838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8671853</ArticleId><ArticleId IdType="pubmed">34906986</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrovorty SK, Hossain KM, Hossain MA, Ahammad S, Kabir MF, Shafin R, et al. Predictors of and factors associated with novel post covid symptoms in the musculoskeletal, functional, and cognitive domains for vaccinated delta-variant survivors: a descriptive survey of a nationwide prospective inception cohort in Bangladesh. SSRN Electron J. 2022. 10.2139/ssrn.4249920.10.2139/ssrn.4249920</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4249920</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruf W. Immune damage in Long Covid. Science [Internet]. 2024;383(6680):262&#x2013;3. 10.1126/science.adn1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">38236985</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabir MF, Yin KN, Jeffree MS, Ahmedy FB, Zainudin MF, Htwe O, Jahan S, Hossain MZ, Hossain KA. Al Mukit10 MA, Hossain11 T. comparing effectiveness of telerehabilitation versus institution-based adapted physical activity and therapeutic exercise program on fatigue, physical functioning, and episodic disability for chronic fatigue syndrome in long covid-19: protocol for a randomized control trial. Chelonian Res Foundation. 2023;18(2):1380&#x2013;95. 10.18011/2023.11(2).1380.1395.10.18011/2023.11(2).1380.1395</Citation><ArticleIdList><ArticleId IdType="doi">10.18011/2023.11(2).1380.1395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabir MF, Yin KN, Jeffree MS, Ahmedy FB, Jahan S, Islam MW, Jahid IK, Sivan M, Chakrovorty SK, Hossain KA. Profile of long COVID symptoms needing rehabilitation: a cross-sectional household survey of 12,925 SARS-CoV-2 cases between July and December 2021 in Bangladesh. Archives Public Health. 2023;81(1):132.10.1186/s13690-023-01140-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13690-023-01140-0</ArticleId><ArticleId IdType="pmc">PMC10351147</ArticleId><ArticleId IdType="pubmed">37461092</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12:1494. 10.3389/fmicb.2021.698169.10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, et al. Is diabetes mellitus associated with case-fatality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr Clin Res Rev. 2020;14:535&#x2013;45. 10.1016/j.dsx.2020.04.044.10.1016/j.dsx.2020.04.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.044</ArticleId><ArticleId IdType="pmc">PMC7200339</ArticleId><ArticleId IdType="pubmed">32408118</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531&#x2013;38. 10.1007/s00392-020-01626-9. 10.1007/s00392-020-01626-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01626-9</ArticleId><ArticleId IdType="pmc">PMC7087935</ArticleId><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802&#x2013;10. 10.1001/jamacardio.2020.0950. 10.1001/jamacardio.2020.0950</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif N, Ahmed SN, Opu RR, Tani MR, Dewan D, Daullah MU, et al. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh. Diabetes Metab Syndr: Clin Res Rev. 2021;15:1009&#x2013;16. 10.1016/j.dsx.2021.05.005.10.1016/j.dsx.2021.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.05.005</ArticleId><ArticleId IdType="pmc">PMC8106201</ArticleId><ArticleId IdType="pubmed">33993046</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811&#x2013;2. 10.1001/jamacardio.2020.1017. 10.1001/jamacardio.2020.1017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S, Grech S. COVID-19 and diabetes: the why, the what and the how. J Diabetes Complications. 2020;34:107637. 10.1016/j.jdiacomp.2020.107637. 10.1016/j.jdiacomp.2020.107637</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2020.107637</ArticleId><ArticleId IdType="pmc">PMC7242955</ArticleId><ArticleId IdType="pubmed">32456846</ArticleId></ArticleIdList></Reference><Reference><Citation>Stengel S, G&#xf6;lz L, Kolb JF, Tarbet K, V&#xf6;ller S, Koetsenruijter J et al. First insights into multidisciplinary and multispecialty long COVID networks&#x2014;a SWOT analysis from the perspective of ambulatory health care professionals. Frontiers in Medicine [Internet]. 2023;10. 10.3389/fmed.2023.1251915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10665561</ArticleId><ArticleId IdType="pubmed">38020101</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangladesh population (live) accessed via Worldometer. 2021. Available: https://www.worldometers.info/world-population/bangladesh-population/.</Citation></Reference><Reference><Citation>Carson G. Research priorities for Long Covid: refined through an international multi-stakeholder forum. BMC Medicine [Internet]. 2021;19(1). 10.1186/s12916-021-01947-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009733</ArticleId><ArticleId IdType="pubmed">33785027</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor RJ, Preston N, Parkin A, Makower S, Ross D, Gee J, Halpin SJ, Horton M, Sivan M. The COVID-19 Yorkshire Rehabilitation Scale (C19&#x2010;YRS): application and psychometric analysis in a post&#x2010;COVID&#x2010;19 syndrome cohort. J Med Virol. 2022;94(3):1027&#x2013;34. 10.1002/jmv.27415. 10.1002/jmv.27415</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27415</ArticleId><ArticleId IdType="pmc">PMC8662016</ArticleId><ArticleId IdType="pubmed">34676578</ArticleId></ArticleIdList></Reference><Reference><Citation>Fei Z, Ryeznik Y, Sverdlov O, Tan CW, Wong WK. An overview of healthcare data analytics with applications to the COVID-19 pandemic. IEEE Transactions on Big Data [Internet]. 2021;1. 10.1109/tbdata.2021.3103458.</Citation></Reference><Reference><Citation>Ballouz T, Menges D, Anagnostopoulos A, Domenghino A, Aschmann HE, Frei A, Fehr JS, Puhan MA. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023;381. 10.1136/bmj-2022-074425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVries A, Shambhu S, Sloop S, Overhage JM. One-Year Adverse Outcomes Among US Adults with Post&#x2013;COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance Database. InJAMA Health Forum 2023 Mar 3 (Vol. 4, No. 3, pp. e230010-e230010). American Medical Association. 10.1001/jamahealthforum.2023.0010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9984976</ArticleId><ArticleId IdType="pubmed">36867420</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q, Yang Y, Wang F, Huang Z, Qiu W, Mao A. Case fatality rates of COVID-19 during epidemic periods of variants of concern: A meta-analysis by continents. International Journal of Infectious Diseases [Internet]. 2024;141:106950. 10.1016/j.ijid.2024.01.017.</Citation><ArticleIdList><ArticleId IdType="pubmed">38309460</ArticleId></ArticleIdList></Reference><Reference><Citation>Uusk&#xfc;la A, J&#xfc;rgenson T, Pisarev H, Kolde R, Meister T, Tisler A et al. Long-term mortality following SARS-CoV-2 infection: A national cohort study from Estonia. the Lancet Regional Health Europe [Internet]. 2022;18:100394. 10.1016/j.lanepe.2022.100394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9051903</ArticleId><ArticleId IdType="pubmed">35505834</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>